Literature DB >> 18579997

Bilateral retinitis following chikun- gunya fever.

Krishna R Murthy1, Nandita Venkataraman, Vidya Satish, Kalpana Babu.   

Abstract

A 35-year-old male with a history of chikungunya fever, presented with diminution of vision in the right eye of one-week duration. His best corrected visual acuity (BCVA) was counting fingers 2 meters and 20/20 (Snellens) in the right and left eyes respectively. A diagnosis of neuroretinitis was made in the right eye while left eye showed features of retinitis. ELISA (serum) and polymerase chain reaction (aqueous) were positive for herpes simplex virus. The lesions did not show any response to antiviral or steroid treatment and appeared to be self-limiting. At five months follow-up, lesions had resolved well with BCVA of 20/120 and 20/20 in the right and left eyes respectively.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18579997      PMCID: PMC2636155     

Source DB:  PubMed          Journal:  Indian J Ophthalmol        ISSN: 0301-4738            Impact factor:   1.848


Chikungunya fever is caused by an alphavirus transmitted to humans by the bite of infected mosquitoes belonging to the genus Aedes.1 Large scale outbreaks of the fever due to the chikungunya fever in south India have been reported recently. We report an interesting case of bilateral retinitis following serologically proven chikungunya fever.

Case Report

A 35-year-old male presented with diminution of vision in the right eye of one-week duration. He was symptomatically treated for serologically proven chikungunya fever three weeks back. On examination, his best corrected visual acuity (BCVA) was counting fingers 2 meters and 20/20 (Snellens) in the right and left eyes respectively. Relative afferent pupillary defect was noted in the right eye. Slit-lamp examination showed a quiet anterior segment and 1 + vitreous cells (Grading: Kimura and colleagues)2 in both eyes. Intraocular pressures were normal. Fundus examination of the right eye showed areas of retinitis and hemorrhages in the posterior pole and hyperemia and blurring of the disc margins (neuroretinitis). In the left eye, a patch of retinitis was seen nasal to the optic disc [Fig. 1A and B]. Fundus fluorescein angiography showed areas of capillary nonperfusion corresponding to the retinitis lesions [Fig. 2A and B] and optical coherence tomography (Stratus version 4, Zeiss, Germany) showed areas of retinal destruction [Fig. 3]. Laboratory investigations included an ESR of 38mm/h, normal hematological and rheological parameters, coagulation profile, blood sugar, liver and renal function, urine analysis and chest X-ray. VDRL test for syphilis and Mantoux test were negative. ELISA showed IgM and IgG positivity for herpes simplex and only IgG positivity for cytomegalovirus and Varicella Zoster viruses. ELISA for HIV and toxoplasma were negative. Aqueous tap was positive for herpes simplex virus. He was started on intravenous acyclovir 1500 mg/m2/day. As the lesions continued to progress [Fig. 4A and B] in both eyes, oral steroids in a dosage of 1 mg/kg body weight were added after four days along with oral acyclovir and intravitreal ganciclovir 2000 micrograms in 0.05 ml in both eyes. Oral acyclovir was stopped after 10 days while the steroids were tapered over four weeks. At the end of four weeks, there was no further deterioration in vision or appearance of any new lesions. At the last follow-up (five months), the retinal lesions had healed well [Fig. 5] and his BCVA was 20/120 and 20/20 in the right and left eyes respectively.
Figure 1A

Fundus photograph of the right eye showing active retinitis

Figure 1B

Fundus photograph of left eye showing active retinitis

Figure 2A

Fluorescein angiogram showing areas of capillary nonperfusion in the right eye

Figure 2B

Fluorescein angiogram showing areas of capillary nonperfusion in the left eye

Figure 3

Optical coherence tomogram of the right eye showing areas of retinal destruction

Figure 4A

Fundus photograph of the right eye showing progression of retinitis

Figure 4B

Fundus photograph of left eye showing progression of retinitis

Figure 5

Fundus photograph of the right eye showing resolved retinitis

Discussion

Ocular manifestations in chikungunya fever are rare and include retroorbital pain, conjunctivitis and choroiditis, (Medline search).3 We report an interesting case of bilateral retinitis in a patient with serologically proven chikungunya fever. As no reports of retinitis after chikungunya fever were available in the literature at the time of examination, tests were done to rule out an infective etiology. ELISA and the PCR results of the serum and the aqueous sample respectively were positive for herpes simplex virus.4-6 As a result, he was started on intravenous acyclovir. As symptoms continued to progress in spite of intravenous acyclovir, an ongoing immune-mediated reaction following the fever was a possibility. Role of corticosteroids and immunosuppression in viral fever is controversial. As a result, he received oral steroids (1 mg/kg body wt) under cover of antivirals. There was no immediate improvement of the retinitis with the above treatment. However, there was no further worsening of the retinitis either. The lesions were self-limiting and took over six to eight weeks to resolve completely. Retrospectively, the interval between the onset of visual symptoms and the systemic manifestations of chikungunya fever in our patient was three weeks. This delay favors the hypothesis that the ocular lesions could be an immune- mediated process rather than a direct viral infection. There may also be an aberrant immune response triggered by the virus resulting in development of autoantibodies against the retina.7 However, in our case, it is difficult to explain the PCR and ELISA positivity to herpes simplex virus and non- responsiveness to antiviral treatment. As this is an isolated case report, it is difficult to postulate the mechanism involved in the development of retinitis. This report highlights the findings and course of bilateral retinitis in a patient with chikungunya fever.
  7 in total

1.  Role of viral serology in the diagnosis of acute retinal necrosis syndrome.

Authors:  Raminder Grover; R K Ratho; V Gupta; R C Mahajan; A Gupta
Journal:  Indian J Pathol Microbiol       Date:  2002-07       Impact factor: 0.740

2.  Signs and symptoms of uveitis. II. Classification of the posterior manifestations of uveitis.

Authors:  S J KIMURA; P THYGESON; M J HOGAN
Journal:  Am J Ophthalmol       Date:  1959-05       Impact factor: 5.258

3.  Ocular manifestations of dengue fever.

Authors:  Wee-Kiak Lim; Ranjana Mathur; Adrian Koh; Ronald Yeoh; Soon-Phaik Chee
Journal:  Ophthalmology       Date:  2004-11       Impact factor: 12.079

4.  Bilateral macular choroiditis following Chikungunya virus infection.

Authors:  B Chanana; R V Azad; S Nair
Journal:  Eye (Lond)       Date:  2007-05-04       Impact factor: 3.775

5.  Proposed antigenic classification of registered arboviruses I. Togaviridae, Alphavirus.

Authors:  C H Calisher; R E Shope; W Brandt; J Casals; N Karabatsos; F A Murphy; R B Tesh; M E Wiebe
Journal:  Intervirology       Date:  1980       Impact factor: 1.763

6.  The diagnostic significance of enzyme linked immuno-sorbent assay for herpes simplex, varicella zoster and cytomegalovirus retinitis.

Authors:  Hajib N Madhavan; Kannian Priya
Journal:  Indian J Ophthalmol       Date:  2003-03       Impact factor: 1.848

7.  Serologic and polymerase chain reaction analysis of intraocular fluids in the diagnosis of infectious uveitis.

Authors:  J H de Boer; C Verhagen; M Bruinenberg; A Rothova; P T de Jong; G S Baarsma; A Van der Lelij; F M Ooyman; J G Bollemeijer; P J Derhaag; A Kijlstra
Journal:  Am J Ophthalmol       Date:  1996-06       Impact factor: 5.258

  7 in total
  13 in total

1.  Immunopathogenesis of alphaviruses.

Authors:  Victoria K Baxter; Mark T Heise
Journal:  Adv Virus Res       Date:  2020-07-08       Impact factor: 9.937

Review 2.  Current approach in the diagnosis and management of posterior uveitis.

Authors:  S Sudharshan; Sudha K Ganesh; Jyotirmay Biswas
Journal:  Indian J Ophthalmol       Date:  2010 Jan-Feb       Impact factor: 1.848

Review 3.  Viral posterior uveitis.

Authors:  Joanne H Lee; Aniruddha Agarwal; Padmamalini Mahendradas; Cecilia S Lee; Vishali Gupta; Carlos E Pavesio; Rupesh Agrawal
Journal:  Surv Ophthalmol       Date:  2016-12-22       Impact factor: 6.048

4.  Chikungunya virus iridocyclitis in Fuchs' heterochromic iridocyclitis.

Authors:  Padmamalini Mahendradas; Rohit Shetty; J Malathi; H N Madhavan
Journal:  Indian J Ophthalmol       Date:  2010 Nov-Dec       Impact factor: 1.848

5.  Post-fever retinitis: a single center experience from south India.

Authors:  Srilatha Vishwanath; Kalpana Badami; K S Sriprakash; B L Sujatha; S D Shashidhar; Y D Shilpa
Journal:  Int Ophthalmol       Date:  2013-12-21       Impact factor: 2.031

6.  A case of atypical ophthalmoplegia after Chikungunya fever.

Authors:  Paromita Dutta; Ankita Sharma
Journal:  Int Ophthalmol       Date:  2017-04-10       Impact factor: 2.029

7.  Arboviruses (chikungunya, dengue, and Zika) associated with ophthalmic changes: a focus on aqueous fluid and vitreous humor.

Authors:  Paulo Alex Neves da Silva; Célia Regina Malveste Ito; Mônica Santiago Barbosa; Mônica de Oliveira Santos; Lilian Carla Carneiro
Journal:  Eur J Clin Microbiol Infect Dis       Date:  2019-12-20       Impact factor: 5.103

Review 8.  Arboviruses and the eye.

Authors:  Gabriel Costa de Andrade; Camila V Ventura; Paulo Augusto de Arruda Mello Filho; Maurício Maia; Silvana Vianello; Eduardo Büchele Rodrigues
Journal:  Int J Retina Vitreous       Date:  2017-02-01

9.  Optical coherence tomography angiography features of bilateral retinopathy associated with Chikungunya fever.

Authors:  Aniruddha Agarwal; Tripti Choudhary; Vishali Gupta
Journal:  Indian J Ophthalmol       Date:  2018-01       Impact factor: 1.848

10.  Chikungunya and the eye: a review.

Authors:  Padmamalini Mahendradas; Kavitha Avadhani; Rohit Shetty
Journal:  J Ophthalmic Inflamm Infect       Date:  2013-02-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.